Stock research
NVNO enVVeno Medical Corporation
Healthcare • Medical - Devices
enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced...…
enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
1Y change
-93.87%
Range high
$177.63
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in NVNO?
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $10.63
- Day High
- $10.60
- Day Low
- $10.60
- 52w High
- $179.55
- 52w Low
- $8.67
- Volume
- 2,295
- Avg Volume
- Beta
- 1.089
* TTM/most recent where available
Company
- Ticker
- NVNO
- Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- US
- CEO
- Robert A. Berman
- Employees
- 33
- Website
- www.envveno.com
Key Metrics
- Market Cap
- 175K
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).